Radiothérapie hypofractionnée des cancers ORL chez le sujet âgé

التفاصيل البيبلوغرافية
العنوان: Radiothérapie hypofractionnée des cancers ORL chez le sujet âgé
المؤلفون: H. Le Caer, Cécile Ortholan, C. Mertens, Anne Auperin, Joël Guigay
المصدر: Cancer/Radiothérapie. 22:640-643
بيانات النشر: Elsevier BV, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Hypofractionated Radiotherapy, medicine.medical_specialty, Fractionated radiotherapy, business.industry, medicine.medical_treatment, Head and neck cancer, Concomitant boost, medicine.disease, Radiation therapy, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Accelerated radiotherapy, Medicine, Split course, Radiology, Nuclear Medicine and imaging, Short course, 030212 general & internal medicine, Radiology, business
الوصف: Thirty percent of patients with head and neck cancer are over 70 years. Radiotherapy approach in elderly is a challenge. On one hand, radiotherapy side effects, as well as the number of sessions required, could be a burden. On the other hand, omission of local treatment is not an option due to the symptoms of the tumor. Patients in good general condition may receive standard fractionnated radiotherapy. For frail patients unsuitable for standard fractionated radiotherapy, more convenient shorter course of radiotherapy are commonly used. Physicians have to choose the best radiotherapy schedule according to the objective of the treatment. In case of palliative intend: hypofractionated radiotherapy delivered with a single short course could be recommanded. This course could be followed by other subsequent courses if the patient's condition improves during the treatment. For patients treated in curative intend, the choice of hypofractionation schedule depends on the general condition: split course hypofractionated radiotherapy for unfit patients, or accelerated radiotherapy with concomitant boost for fit patients. In all cases, a high-quality radiotherapy technique and appropriate supportive care are mandatory to minimize the side effects. The ELAN RT trial, soon to be completed, will rule on the non-inferiority of hypofractionated radiotherapy compared to standard radiotherapy for unfit patients.
تدمد: 1278-3218
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9ee6eb680d2ded0ae34c467a47b3a3cdTest
https://doi.org/10.1016/j.canrad.2018.06.008Test
حقوق: CLOSED
رقم الانضمام: edsair.doi...........9ee6eb680d2ded0ae34c467a47b3a3cd
قاعدة البيانات: OpenAIRE